07:47 AM EDT, 07/17/2025 (MT Newswires) -- Fulgent Genetics ( FLGT ) said Thursday that it has received CE certification under the European Union's In Vitro Diagnostic Regulation for its germline next-generation sequencing system, which includes FulgentExome and Fulgent Pipeline Manager.

FulgentExome analyzes over 4,600 genes to detect clinically relevant genetic variants associated with a patient's symptoms and history, the company said.

The Fulgent Pipeline Manager software helps interpret sequencing data within this system, the company added.